Paul J. Mellett is CFO & Treasurer at ENANTA PHARMACEUTICALS INC (ENTA). They have made 8 open-market trades across 1 company since 2014, most recently 2025-02-12.
CIK 0001185034
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENTA | 99,210 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2025-02-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENTA | SELL | 2024-12-06 | 2024-12-10 | $8.06 | $21K | -26.5% | -40.5% | -20.8% |
| ENTA | SELL | 2023-12-05 | 2023-12-06 | $9.63 | $23K | -5.6% | +27.9% | +59.0% |
| ENTA | SELL | 2023-03-15 | 2023-03-17 | $44.43 | $923K | -5.4% | -10.7% | -43.2% |
| ENTA | SELL | 2023-02-09 | 2023-02-13 | $53.76 | $269K | -5.2% | -12.0% | -48.9% |
| ENTA | SELL | 2021-01-08 | 2021-01-08 | $45.58 | $273K | +2.7% | +20.6% | +8.2% |
| ENTA | SELL | 2020-01-02 | 2020-01-06 | $60.85 | $1.2M | -4.8% | -9.3% | -17.5% |
| ENTA | SELL | 2018-06-11 | 2018-06-12 | $120.72 | $3.3M | +4.7% | +10.2% | -20.5% |
| ENTA | SELL | 2018-03-19 | 2018-03-20 | $86.48 | $778K | -5.2% | -0.2% | +32.0% |
| ENTA | SELL · 10b5-1 | 2015-11-24 | 2015-11-25 | $30.15 | $181K | -17.8% | +5.4% | -13.4% |
| ENTA | SELL · 10b5-1 | 2015-10-15 | 2015-10-16 | $40.10 | $301K | -17.8% | +5.4% | -13.4% |
| ENTA | SELL · 10b5-1 | 2015-09-08 | 2015-09-10 | $39.55 | $297K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2015-08-07 | 2015-08-10 | $42.85 | $321K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2015-07-13 | 2015-07-14 | $46.30 | $347K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2015-06-11 | 2015-06-12 | $42.51 | $319K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2015-05-19 | 2015-05-20 | $40.13 | $963K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2015-01-16 | 2015-01-20 | $49.45 | $223K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-11-28 | 2014-12-02 | $47.31 | $284K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-10-20 | 2014-10-22 | $45.46 | $182K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-09-15 | 2014-09-16 | $39.83 | $398K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-08-14 | 2014-08-15 | $39.13 | $391K | -17.8% | +5.4% | +5.4% |
| ENTA | SELL · 10b5-1 | 2014-07-14 | 2014-07-16 | $39.89 | $798K | -17.8% | +5.4% | +5.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.